plemmons and co-authors disclosed no relevant relationships with industry.
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
.
.
the senate included a provision similar to cusack's bill in its omnibus health care overhaul legislation passed last november, according to sen.
.